Back to companies

Novo

DKNasdaq CopenhagenPharmaceuticals & Healthcare

Novo

Revenue
DKK 309.1bn
FY2025
Operating income
—
FY2025
Employees
—
Founded
1923

Source: Wikidata (CC0)